Presented on November 26, 2018
Authors:
Brian S. Metzger, MD, MPH – Austin Infectious Disease Consultants, Austin, TX
John S. Adams, MD, FIDSA, FSHEA – Knoxville Infectious Disease Consultants, P.C., Knoxville, TN
Jorge R. Bernett, MD – Infectious Disease Doctors Medical Group, Walnut Creek, CA
Richard M. Mandel, MD, FIDSA – Southern Arizona Infectious Disease Specialists, PLC, Tucson, AZ
Richard C. Prokesch, MD, FACP, FIDSA – Infectious Diseases Associates, Riverdale, GA
Carson T Lo, MD – West Houston Infectious Disease Associates, Katy, TX
Thomas C Hardin, PharmD – Healix Infusion Therapy, Sugar Land, TX
Claudia P Schroeder, PharmD, PhD – Healix Infusion Therapy, Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX